physostigmine transdermal system (Lohmann)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namephysostigmine transdermal system (Lohmann)
Drug Alias Namephysostigmine(-)-physostigminephysostigmine transdermal system (Klinge)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKlinge Pharma Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLts Lohmann Therapie-Systeme AgKlinge Pharma Gmbh
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A